한글목차

세계의 흉부 대동맥류 시장은 2024년에 32억 8,000만 달러로 평가되었으며, 2030년에는 CAGR 4.77%를 나타내 76억 1,000만 달러에 이를 것으로 예상됩니다.

이 배경에는 심혈관 질환의 유병률 증가, 진단 기술의 진보, 조기 발견·치료에 대한 의식이 높아집니다. 흉부 대동맥류는 흉부 대동맥의 비정상적인 팽창을 특징으로하며, 방치하면 생명을 위협하는 파열을 포함하여 심각한 건강 위험을 초래합니다.

혈관 내 동맥류 수복술(EVAR) 등 기존의 개복 수술에 비해 보다 안전하고 효과적인 치료법을 제공하는 저침습 수술 기술 혁신이 시장 확대를 지원하고 있습니다. 주요 과제로는 고급 수술 및 장치 비용이 높고 특정 지역에서는 전문 의료시설에 대한 접근이 제한되어 있으며 시장 침투를 제한 할 수 있습니다.

주요 시장 성장 촉진요인

건강 관리 산업의 성장

주요 시장 과제

진단 지연 및 무증상성

주요 시장 동향

고급 의료 및 개인화 치료

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 COVID-19가 세계의 흉부 대동맥류 시장에 미치는 영향

제5장 세계의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
  • 금액별
• 시장 점유율·예측
  • 치료(개방형 수술적 수복술(OSR), 흉부 내혈관 동맥류 수복술(TEVAR), 하이브리드 수술, 분지형 내혈관 동맥류 수복술(BEVAR), 기타)
  • 용도별(병원, 외래수술센터(ASC), 진료소, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 흉부 대동맥류 시장 전망

• 시장 규모와 예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 합병과 인수
• 제품 출시
• 최근 동향

제13장 혼란 : 분쟁, 유행, 무역 장벽

제14장 세계의 흉부 대동맥류 시장 : SWOT 분석

제15장 Porter's Five Forces 분석

• 업계 내 경쟁
• 신규 진입의 가능성
• 공급자의 힘
• 고객의 힘
• 대체품의 위협

제16장 경쟁 구도

• Medtronic plc
• WL Gore & Associates, Inc.
• Cook Medical Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Artivion Inc.
• Cardiatis SA
• Endologix Inc.
• Braile Biomedica

제17장 전략적 제안

제18장 기업 소개와 면책사항

영문목차

Global Thoracic Aortic Aneurysm Market was valued at USD 3.28 Billion in 2024 and is expected to reach USD 7.61 Billion by 2030 with a CAGR of 4.77%. This is driven by increasing prevalence of cardiovascular diseases, advances in diagnostic technologies, and rising awareness about early detection and treatment. Thoracic aortic aneurysm, characterized by the abnormal bulging of the aorta in the chest region, poses significant health risks including life-threatening ruptures if left untreated.

Market expansion is supported by technological innovations in minimally invasive surgical techniques, such as endovascular aneurysm repair (EVAR), which offer safer and more effective treatment options compared to traditional open surgery. Key challenges include the high cost of advanced surgical procedures and devices, as well as limited accessibility to specialized healthcare facilities in certain regions, which may restrict market penetration.

Key Market Drivers

Growth in Healthcare Industry

The rapid growth of the global healthcare industry is a significant driver propelling the expansion of the thoracic aortic aneurysm (TAA) market. The global healthcare industry generates annual sales exceeding USD 4 trillion. The largest and most lucrative segments are pharmaceuticals and biotechnology, accounting for nearly USD 850 billion, and medical technology and diagnostics, which exceed USD 400 billion in revenue. Increased healthcare expenditure, advancements in diagnostic technologies, and the rising prevalence of cardiovascular diseases are collectively fueling demand for effective TAA detection and treatment solutions worldwide.

As healthcare infrastructure improves globally, more patients are gaining access to specialized cardiovascular care, leading to higher diagnosis rates and increased adoption of surgical and minimally invasive interventions for thoracic aortic aneurysms. The PEN-Plus strategy decentralizes specialized cardiovascular care to district hospitals by reallocating responsibilities to multidisciplinary teams of midlevel professionals. It aims to ensure sustainability by enhancing health literacy to encourage self-management, leveraging community health workers to improve patient retention, engaging peer-support groups, and establishing clear referral and counter-referral pathways for patients with cardiovascular disease (CVD). Furthermore, growing awareness about cardiovascular health and early screening initiatives are contributing to market growth.

Key Market Challenges

Late Diagnosis and Asymptomatic Nature

One of the primary challenges confronting the global thoracic aortic aneurysm market is the condition's asymptomatic nature, which often leads to late diagnosis. Many patients with thoracic aortic aneurysms remain unaware of their condition until symptoms manifest in advanced stages or until life-threatening complications, such as aortic rupture or dissection, occur. This silent progression significantly complicates timely intervention and treatment.

The lack of early, noticeable symptoms poses a major barrier for healthcare providers in identifying at-risk individuals before critical damage occurs. Consequently, patients frequently present with the disease at a stage when therapeutic options are more complex, invasive, and associated with higher risks. Moreover, limited awareness among the general population and inadequate routine screening protocols contribute to delayed detection.

Key Market Trends

Advanced Clinical Practices and Personalized Treatment

The adoption of advanced clinical practices and personalized treatment approaches is a key trend shaping the global thoracic aortic aneurysm (TAA) market. Open-chest thoracic aortic aneurysm repair continues to be the standard surgical treatment for thoracic aortic aneurysms (TAAs), representing the established approach for managing this condition. This procedure remains the preferred method due to its proven effectiveness in addressing complex aneurysms within the thoracic aorta. Innovations in diagnostic imaging, genetic profiling, and minimally invasive surgical techniques are enabling healthcare providers to tailor interventions more precisely to individual patient needs.

Personalized treatment strategies, supported by enhanced risk assessment tools and patient-specific data, are improving the accuracy of aneurysm detection, monitoring, and management. This approach reduces complications, optimizes therapeutic outcomes, and enhances patient quality of life. Moreover, the integration of multidisciplinary care teams and the use of advanced endovascular devices reflect a broader shift towards precision medicine in TAA treatment.

Key Market Players

• Medtronic plc
• W.L. Gore & Associates, Inc.
• Cook Medical Inc.
• Terumo Corporation
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• Artivion Inc.
• Cardiatis S.A.
• Endologix Inc.
• Braile Biomedica

Report Scope

In this report, the Global Thoracic Aortic Aneurysm Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Thoracic Aortic Aneurysm Market, By Treatment:

• Open Surgical Repair (OSR)
• Thoracic Endovascular Aneurysm Repair (TEVAR)
• Hybrid Procedures
• Branched Endovascular Aneurysm Repair (BEVAR)
• Others

Thoracic Aortic Aneurysm Market, By End Use:

• Hospitals
• Ambulatory surgery centers (ASC)
• Clinics
• Others

Thoracic Aortic Aneurysm Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Thoracic Aortic Aneurysm Market.

Available Customizations:

Global Thoracic Aortic Aneurysm Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Thoracic Aortic Aneurysm Market

5. Global Thoracic Aortic Aneurysm Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment (Open Surgical Repair (OSR), Thoracic Endovascular Aneurysm Repair (TEVAR), Hybrid Procedures, Branched Endovascular Aneurysm Repair (BEVAR), Others)
  • 5.2.2. By End Use (Hospitals, Ambulatory surgery centers (ASC), Clinics, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Thoracic Aortic Aneurysm Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Thoracic Aortic Aneurysm Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Thoracic Aortic Aneurysm Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Thoracic Aortic Aneurysm Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment
      • 6.3.3.2.2. By End Use

7. Europe Thoracic Aortic Aneurysm Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Thoracic Aortic Aneurysm Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Thoracic Aortic Aneurysm Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Thoracic Aortic Aneurysm Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Thoracic Aortic Aneurysm Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Thoracic Aortic Aneurysm Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment
      • 7.3.5.2.2. By End Use

8. Asia Pacific Thoracic Aortic Aneurysm Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Thoracic Aortic Aneurysm Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Thoracic Aortic Aneurysm Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Thoracic Aortic Aneurysm Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Thoracic Aortic Aneurysm Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Thoracic Aortic Aneurysm Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment
      • 8.3.5.2.2. By End Use

9. South America Thoracic Aortic Aneurysm Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Thoracic Aortic Aneurysm Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Thoracic Aortic Aneurysm Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Thoracic Aortic Aneurysm Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Thoracic Aortic Aneurysm Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Thoracic Aortic Aneurysm Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Thoracic Aortic Aneurysm Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Thoracic Aortic Aneurysm Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Global Thoracic Aortic Aneurysm Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Medtronic plc
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. W.L. Gore & Associates, Inc.
• 16.3. Cook Medical Inc.
• 16.4. Terumo Corporation
• 16.5. MicroPort Scientific Corporation
• 16.6. Boston Scientific Corporation
• 16.7. Artivion Inc.
• 16.8. Cardiatis S.A.
• 16.9. Endologix Inc.
• 16.10. Braile Biomedica

17. Strategic Recommendations

18. About Us & Disclaimer